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Abstract
Background: In 2000, an Italian non-governmental organisation (NGO) began a 9-year project to establish a surgical
pathology laboratory at the Bugando Medical Centre (BMC) in Mwanza, Tanzania, a country with a low Human
Development Index (HDI), and as of 2009, the laboratory was operating autonomously. The present survey aims to evaluate
the reproducibility of histological and cytological diagnoses assigned in the laboratory’s early years of autonomous activity.
We selected a random sample of 196 histological and cytological diagnoses issued in 2010–2011 at the BMC surgical
pathology laboratory. The corresponding samples were sent to Italy for review by Italian senior pathologists, who were
blinded to the local results. Samples were classified into four diagnostic categories: malignant, benign, inflammatory, and
suspicious. The two-observer kappa-statistic for categorised (qualitative) data was then calculated to measure diagnostic
concordance between the local Tanzanian pathologists and Italian senior pathologists. The k-Cohen was calculated for
concordance in the overall study sample. Concordance and discordance rates were also stratified by subset: general adult,
paediatric/adolescent, and lymphoproliferative histopathological diagnoses; fluid and fine needle aspiration (FNA)
cytological diagnoses; and PAP tests. Discordance was also categorised by the corresponding hypothetical clinical
implications: high, intermediate, and not significant.
Results: Overall concordance was 85.2% (167 of 196 diagnoses), with a k-Cohen of 0.7691 (P = 0.0000). Very high
concordance was observed in the subsets of adult general pathological diagnoses (90%) and paediatric/adolescent
pathological diagnoses (91.18%). Concordance in the subset of PAP tests was 75%, and for fluid/FNA cytological
diagnoses it was 56.52%. Concordance among 12 histological subtypes of lymphoma was 75.86%, with substantial
discordance observed in the diagnosis of Burkitt lymphoma (five cases diagnosed by Italian pathologists versus 2 by local
pathologists). The overall proportion of discordance with high hypothetical clinical implications was 6.1% (12 diagnoses).
Conclusion: This blind review of diagnoses assigned in Tanzania, a country with low HDI, and in Italy, a country with a
very high HDI, seemed to be a sensitive and effective method to identify areas of potential error and may represent a
reference point for future, more detailed quality control processes or audits of surgical pathology services located in
limited-resource regions.
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Background
The United Republic of Tanzania is located in East Africa
and has a low Human Development Index (HDI), ranking
159th out of the 187 countries classified by the United
Nations Development Programme [24]. The Bugando
Medical Centre (BMC) is one of four main referral hospi-
tals in Tanzania. It is a 900-bed facility that also serves as
a consulting and teaching hospital for the Catholic
University of Health and Allied Sciences. Located in
Mwanza, the second largest city in Tanzania, the BMC
employs approximately 950 people and serves a catch-
ment area of approximately 13 million inhabitants in the
northwestern “Lake Zone”, i.e., one-third of the country’s
total population of about 40 million.
In 2000, a 9-year project was started, the Mwanza histo-
pathology project, to establish a surgical pathology labora-
tory at the BMC. This project was funded by the Italian
charity “Vittorio Tison Association” (http://www.associa-
zionevittoriotison.org) and carried out by the Italian non-
governmental organisation (NGO) “Pathologists beyond
borders” (Associazione Patologi Oltre Frontiera; http://
www.apof.eu/). The project included the training of local
staff (two pathologists, one histotechnologist, and one lab
technician), and the continued presence of Italian senior
pathologists, histotechnologists, and biologists through
monthly rotations. Their role was to run the histopath-
ology activities while training and supervising the local
pathologists and lab technicians. Their presence ended at
the end of 2008, and as of 2009 the laboratory was operat-
ing autonomously.
Currently, the BMC surgical pathology laboratory
renders about 3,500 histological and 800 cytological diag-
noses per year. This represents a unique reality in this
sub-Saharan African region, where the physician-to-
population ratio is one of the lowest in the world
(1:23,000), and there are just 15 pathologists in the entire
nation [17]. But practicing pathology in this resource-
limited setting is a strenuous challenge [17] and may affect
the quality of diagnoses. Furthermore, evaluating the
performance of professionals is a core necessity in any
health system and has been the object of much debate in
the literature, especially in this post-genome era. This has
generated more demands on pathology departments, as
well as a commitment from pathologists to strive for the
highest quality possible in their laboratories [5, 9, 11, 19].
Finally, as in many other sub-Saharan African countries,
the cancer burden in Tanzania is increasing [1]. The most
common female malignancy is cervical cancer, and child-
hood malignancies are also quite common, including
lymphomas like Burkitt lymphoma (BL). In the early 1990s,
female breast cancer represented about 8.1% of all cancers
in women, but it is now on the rise, and women present at
a younger age than in Western countries [2, 17]. Non-
Hodgkin lymphoma, Kaposi sarcoma, foot melanoma, and
cancers of the bladder, esophagus, stomach, and prostate
are the most common tumours in men [7, 14, 17]. Given
this rise in disease, the BMC surgical pathology laboratory
has the potential to play a key role in providing cancer sta-
tistics, and to contributing to secondary cancer prevention
and cancer control nationwide. However, to accomplish
this, the laboratory must adhere to the best quality stan-
dards possible, with a special emphasis on diagnostic issues.
For this reason, this survey evaluated the reproducibil-
ity of histological and cytological diagnoses assigned in
the early years of autonomous activity (2010–2011) of
the BMC surgical pathology laboratory, with the aim to
assess the capability of local staff to provide histopatho-
logical and cytopathological services at a reasonable level
of quality in a limited-resource country.
Methods
The present survey is based on a sample representing 5%
of the average number of diagnoses assigned annually at
the BMC surgical pathology laboratory. To achieve this,
we selected one of every 45 consecutive histological re-
ports and one of every 40 consecutive cytological reports
issued from July 2010 (after the approval of the collabor-
ation between the BMC surgical pathology laboratory and
Italian organisations from the Tanzanian Ministry of
Health and Social Welfare) to June 2011 from the labora-
tory’s registry book, until we reached 172 histological and
43 cytological reports. Reports were selected in such a
way that every calendar month was represented. Reports
were then categorised into the following subsets: general
adult pathological diagnoses, paediatric/adolescent patho-
logical diagnoses (age 0–19 years), lymphoproliferative
pathological diagnoses, fluid and fine needle aspiration
(FNA) cytological diagnoses, and PAP tests.
Corresponding samples were then sent from the BMC
surgical pathology laboratory to Italy for review by Italian
senior pathologists (chiefs of pathology departments of
public Italian hospitals and universities). These included
haematoxylin-eosin slides, histology blocks to determine
the subtype of lymphoproliferative pathologies by immu-
nohistochemistry (as appropriate), and papanicolau-stained
fluid/FNA cytological slides and cervical smears. The
Italian reviewers were blinded to the local diagnosis
assigned by their Tanzanian counterparts, but they were
given all available clinical history, as well as the type of
biopsy and the site from which it was taken. The Italian re-
viewers assigned their own diagnoses, which were then
classified into the same four diagnostic categories used by
local pathologists, i.e., malignant, benign, inflammatory,
and suspicious (cervical intraepithelial neoplasia grades 1
and 2 were categorised as malignant and atypical squa-
mous cells of undetermined significance as suspicious).
We calculated the two-observer kappa-statistic for
categorised (qualitative) data in the overall study sample
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to measure concordance between diagnoses assigned by
local pathologists and Italian senior pathologists accord-
ing to Cohen [4] and Fleiss [8]. The standard error of k-
statistics for the overall sample was computed under the
z statistic. The k value was ranked according to Landis
and Kock [13] as poor (0 – 0.2), fair (0.21 – 0.4), moder-
ate (0.41 – 0.6), substantial (0.61 – 0.8), or almost per-
fect (>0.8). We then calculated concordance and
discordance rates stratified by subset. Concordance
among lymphoproliferative pathological diagnoses was
also computed for the 12 subtypes of lymphoma. Finally,
discordance was also categorised by the corresponding
hypothetical clinical implications: high (malignant versus
benign; any cervical intraepithelial neoplasia versus be-
nign/inflammatory for PAP tests); intermediate (suspi-
cious and atypical squamous cells of undetermined
significance versus benign/inflammatory; differences in
subtypes of lymphoma); and not significant (benign ver-
sus inflammatory). The statistical package STATA 10.0
was used for the analysis.
Results
Our study sample was based on a final number of 196
diagnoses, because 19 slides were damaged or misplaced
during transport to Italy. The final samples corresponded
to 90 general adult pathological diagnoses, 34 paediatric/
adolescent pathological diagnoses, 29 lymphoproliferative
pathological diagnoses, 23 fluid/FNA cytological diagnoses
and 20 PAP tests. The original diagnoses from the BMC
surgical pathology laboratory were related to the following
anatomical sites: cervix uteri (42, including PAP tests,
21.4%), lymph nodes (29, 14.8%), female breast (17, 8.7%),
skin (16, 8.2%), prostate and intraabdominal organs (12
each, 6.1% each), ovary (11, 5.6%), small and large bowel
(7, 3.6%), thyroid and bone (6 each, 3.1% each), kidney (5,
2.5%), submandibular tissue (4, 2.1%), oesophagus (3,
1.5%), and testis (2, 1%). Apart from PAP tests, there were
more samples from females than males (109 and 63 sam-
ples, respectively), and most of the patients were 20 to
50 years of age (accounting for 80 of 196 cases, 40.8%); 56
cases were under 20 years of age (28.6%) (Table 1).
Concordance in the overall study sample was 85.20% (k-
Cohen 0.7691, P = 0.0000), with concordance in 167 of 196
diagnoses (77 malignant, 67 benign, 21 inflammatory, and
two suspicious). Discordance occurred in six samples classi-
fied as malignant by Italian reviewers but reported as be-
nign (n = 5) or inflammatory (n = 1) by BMC pathologists,
three samples classified as benign by Italian reviewers that
were reported as malignant by BMC pathologists, and three
samples classified as inflammatory according to Italian re-
viewers that were reported as malignant by BMC patholo-
gists (Table 2).
In the subset of lymphoproliferative pathological diagno-
ses (n = 29), concordance was 93.1% when the analysis was
based on the four main diagnostic categories. In fact, there
was a disagreement for malignancy in only two instances:
one Italian-diagnosed non-Hodgkin unclassifiable lymph-
oma versus BMC-diagnosed inflammatory; and one Italian-
diagnosed T-Cell lymphoma versus BMC-diagnosed thym-
oma. However, when we looked at the agreement by histo-
logical subtype of lymphoma, the concordance decreased
to 75.86% (Table 3). Discordance was observed in the diag-
nosis of BL (five cases diagnosed by Italian reviewers versus
two at the BMC; the remaining BMC diagnoses included
two diffuse large B-cell lymphoma; and one lymphoblastic
lymphoma) and diffuse large B-cell lymphoma (five cases
diagnosed by Italian reviewers versus eight at the BMC).
There was 90% concordance in the subset of 90 adult
general pathological diagnoses when the analysis was based
on the four main diagnostic categories (Table 4). However,
when considering the specific histological subtypes of these
diagnoses the concordance decreased slightly to 87.80%
(detailed data not shown). A high concordance (91.18%)
was also observed in the subset of 34 paediatric/adoles-
cence pathological diagnoses when the analysis was based
on the four main diagnostic categories, but when the spe-
cific histological subtypes of these diagnoses were consid-
ered, the concordance decreased to 76.47% (detailed data
not shown). For the 23 fluid/FNA cytological diagnoses, the
concordance was 56.52%. Finally, the concordance in the
20 PAP tests was 75% (Table 4).
Table 5 shows that, in order of decreasing magnitude,
diagnostic discordance with high hypothetical clinical im-
plications accounted for 13.0% (three of 23 diagnoses) of
the subset of fluid/FNA cytological diagnoses, 6.9% (two of
29 diagnoses) of the lymphoproliferative pathological diag-
noses, 5% (one of 20 diagnoses) of the PAP tests, 2.9% (one
of 34 diagnoses) of paediatric/adolescent pathological diag-
noses, and 2.5% (five of 90 diagnoses) of the general adult
pathological diagnoses. Overall, high hypothetical clinical
implications were found in 12 diagnoses (6.1%). Discord-
ance with intermediate hypothetical clinical implications
was found in 12 cases: five (21.7%) fluid/FNA cytological
diagnoses, four lymphoproliferative subtype histological
diagnoses (13.8%), two (2.2%) general adult pathological
diagnoses and one (5%) PAP test. Discordance with no clin-
ical significance was found in ten cases: three PAP tests
(15%), two fluid/FNA cytological diagnoses (8.7%), two gen-
eral adult pathological diagnoses (2.2%), two paediatric/ado-
lescent pathological diagnoses (5.9%) and one
lymphoproliferative pathological diagnosis (3.4%) (Table 5).
Figure 1 depicts the breakdown of cases by subset,
indicating number of discordant diagnoses and their
clinical significance.
Discussion
To the best of our knowledge, this work is the first on the
reproducibility of histological and cytological diagnoses
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from a hospital located in a low-HDI country where a
surgical pathology laboratory has been operating autono-
mously for just over 2 years. Furthermore, this review is
inter-departmental, inter-continental, independent, and
blinded, which makes it different from many others
studies that used an intra-departmental approach [9, 22].
Similarly, but not equally, to the error definition by
Renshaw [18], we looked at the hypothetical clinical impli-
cations of discordance, and separated them into high
hypothetical clinical implications (those in which treat-
ment or prognosis might be different and likelihood of
significantly altering patient investigation and treatment),
intermediate hypothetical clinical implications (those in
which the second opinion was not definitive to modify
clinical management substantially), and no significant











Cervix 21 1 - - 20 42 (21.4%)
Lymphnode - - 22 7 - 29 (14.8%)
Breast female 6 4 - 7 - 17 (8.7%)
Skin 11 5 - - - 16 (8.2%)
Prostate 12 - - - - 12 (6.1%)
Intrabdominal 6 1 - 5 - 12 (6.1%)
Ovary 6 2 3 - - 11 (5.6%)
Small/Large bowel 5 2 - - - 7 (3.6%)
Thyroid 5 - - 1 - 6 (3.1%)
Bone - 6 - - - 6 (3.1%)
Kidney 2 3 - - - 5 (2.5%)
Submandibular 3 1 - - - 4 (2.1%)
Oesophagus 3 - - - - 3 (1.5%)
Testis 2 - - - - 2 (1.0%)
Other 5 9 4 3 - 21 (10.7%)
Total 90 34 29 23 20 196 (100%)
Sex
F 57 21 16 15 20 129 (65.8%)
M 33 12 10 8 - 63 (32.2%)
Unknown - 1 3 - - 4 (2.0%)
Total 90 34 29 23 20 196 (100%)
Age (years)
0–19 0 34 14 7 1 56 (28.6%)
20–50 54 - 9 7 10 80 (40.8%)
51–74 24 - 1 7 2 34 (17.4%)
75+ 8 - 2 2 0 10 (5.1%)
Unknown 4 - 5 0 7 16 (8.2%)
Total 90 34 29 23 20 196 (100%)
FNA fine needle aspiration




Agreement Kappa St. error Prob > z
85.20% 0.7691 0.0505 0.0000
Italian reviewer
Malignant Benign Inflammatory Suspicious Total
Malignant 77 3 3 3 86
Benign 5 67 3 0 75
Inflammatory 1 6 21 4 32
Suspicious 0 1 0 2 3
Total 83 77 27 9 196
BMC Bugando Medical Centre
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hypothetical clinical implications (those that did not imply
different or relevant approaches to clinical management).
The overall findings showed a substantial concordance
between external reviewers from a country with very high
HDI and local pathologists from a country with a low
HDI, and this concordance was very high in adult general
and paediatric/adolescent pathological diagnoses. This
indicates that, for the most common pathologies that exist
in the Lake Region of Tanzania, there is a very high
chance of receiving a reliable diagnosis based on the four
diagnostic categories we considered (malignant, benign,
inflammatory, or suspicious). We observed discordance
with high hypothetical clinical implications in only 6.1% of
diagnoses. Moreover, concordance was quite high even for
lymphoproliferative diagnoses and for the histological sub-
types of lymphoma. This is surprising because the original
diagnoses were not supported by immunohistochemistry,
which is not available at the local level. However, this may
be one reason for the considerable discordance in one
case of benign thymoma diagnosed at the BMC, which
was diagnosed as a T-cell lymphoma in the Italian review,
as well as one case of non-Hodgkin lymphoma and three
cases of BL that were missed by BMC pathologists. It is
worth mentioning that a standard diagnosis of BL should
always be supported by the recommended algorithmic
approach of Naresh et al. [15]. This discordance might be
associated to a 6.9% of error with high hypothetical
clinical implications. The few instances of discordance we
observed in general adult pathological diagnoses were not
related to the lack of immunohistochemistry. For example,
one case of focal prostatic adenocarcinoma diagnosed by
BMC pathologists was not mentioned by the Italian
reviewer. In our opinion, these pathologists could come to
a consensus on this and other cases of discordance on
suspicious cases if a consensus conference were possible.
To a lesser extent, the discordance observed in PAP tests
could be related to the absence of screening programmes
at the time of this survey. Moreover, discordance was not
related to the misclassification of invasive cervical cancer
(in fact it refers to low-grade squamous intraepithelial le-
sions), and finally, seven and six of 20 smears were
defined as technically insufficient or satisfactory with limi-
tations, respectively, by the Italian reviewer.




BL DLBCL FL HL INFL KAPOSI LG LBL NHL-NOS PBL TCL THYMOMA TOTAL
BURKITT 2 0 0 0 0 0 0 0 0 0 0 0 2
DLBCL 2 5 0 0 0 0 0 0 0 1 0 0 8
FOLLICULAR 0 0 2 0 0 0 0 0 0 0 0 0 2
INFLAMMATORY 0 0 0 0 7 0 0 0 0 0 0 0 7
HODGKIN LYMPH. 0 0 0 3 0 0 1 0 0 0 0 0 4
KAPOSI 0 0 0 0 0 1 0 0 0 0 0 0 1
LYMPHOMATOID GR. 0 0 0 0 0 0 0 0 0 0 0 0 0
LYMPHOBLASTIC 1 0 0 0 0 0 0 1 0 0 0 0 2
NHL-NOS 0 0 0 0 1 0 0 0 1 0 0 0 2
PLASMABLASTIC 0 0 0 0 0 0 0 0 0 0 0 0 0
T-CELL LYMPH. 0 0 0 0 0 0 0 0 0 0 0 0 0
THYMOMA 0 0 0 0 0 0 0 0 0 0 1 0 1
TOTAL 5 5 2 3 8 1 1 1 1 1 1 0 29
BL BURKITT LYMPHOMA, BMC Bugando Medical Centre, DLBCL DIFFUSE LARGE B-CELL LYMPHOMA, FL FOLLICULAR LYMPHOMA, HL HODGKIN LYMPHOMA,
INFL INFLAMMATORY, LG LYMPHOMATOID GRANULOMATOSIS, NHL-NOS NOH HODGKIN LYMPHOMA UNCLASSIFIABLE, PBL PLSMABLASTIC LYMPHOMA, TCL
T-CELL LYMHOMA
Table 4 Diagnostic concordance by the four diagnostic









90 81 (90.00%) 79 (87.80%)
Paediatric/adolescent
pathological diagnoses
34 31 (91.18%) 26 (76.47%)
Lymphoproliferative
pathological diagnoses
29 27 (93.10%) 22 (75.86%)
Fluid/FNA cytological
diagnoses
23 13 (56.52%) -
PAP tests 20 15 (75.00%) -
FNA fine needle aspiration
(a) = on the basis of malignant/benign/inflammatory/suspicious categories
(b) = on the basis of specific histo-types
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Technical issues may also be responsible for the worst
results and for the high hypothetically clinically significant
implications found in the subset of fluid/FNA cytological
diagnoses: in fact, none of the cytological slides were con-
sidered technically satisfactory by the Italian reviewer, who
considered them insufficient or just sufficient for staining,
and/or thickness, and/or cellular representativeness of
smear. This could be related to the main problems facing the
practice of pathology in Tanzania reported by Ngoma and
Diwani [16] and Stefan et al. [23], i.e., a low number of histo-
pathology technicians, poor recruitment of these technicians,
and difficulty in obtaining and replacing essential reagents.
This analysis has some limitations: it is not a comprehen-
sive evaluation of errors in surgical pathology according to
Table 5 Diagnostic discordance in the subsets by the four diagnostic categories and hypothetical clinical implications
SUBSET Number Discordance by four
categories(a)
High Intermediate Not significant
General adult pathology 90 9 (10.0%) 5(5.6%) 2 (2.2%) 2 (2.2%)
Paediatric/adolescence 34 3 (8.8%) 1 (2.9%) 0 2 (5.8%)
Lymphoproliferative 29 2 (6.9%) 2 (6.9%) - -
Fluid/FNA cytological diagnoses 23 10 (43.5%) 3(13.0%) 5 (21.7%) 2 (8.7%)
PAP test 20 5 (25.0%) 1 (5.0%) 1 (5.0%) 3(15.0%)
Overall 196 29 (14.8%) 12 6.1%) 8 (4.1%) 9 (3.6%)
Lymphoproliferative by
histological subtype (b)
29 7 (24.1%) 2 (6.9%) 4 (13.8%) 1 (3.4%)
FNA fine needle aspiration
(a) = on the basis of malignant/benign/inflammatory/suspicious categories
(b) = on the basis of 12 histo-types
Fig. 1 Breakdown of the 196 diagnoses by subset, concordance and discordance (*), and hypothetical clinical implications. (*): Discordance on
the basis of malignant/benign/inflammatory/suspicious classification.
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Renshaw [18], because we did not proceed to the second
step, which involves revision of discordant diagnoses by the
original pathologist and the second reviewer together, and
an eventual third step (submission of cases to a third, out-
side reviewer as a “gold standard” in the event of lack of
consensus of the first two observers) in order to classify de-
finitive diagnostic errors. The sample was probably not
large enough to detect a reasonable percentage of errors ac-
cording to Renshaw et al. [22], and finally, we did not assess
discordance by other, more detailed, important correlates
like grade of differentiation in tumours or specific morpho-
logical prognostic characteristics [9].
With regard to the sample size, we assumed that the ini-
tial number of 215 diagnoses was appropriate and would
represent the best available data on the performance of a
surgical pathology laboratory operating in sub-Saharan
Africa. According to Cantor [3], the final overall sample of
196 cases seems reasonable to detect an inter-rater agree-
ment in the range of 30 to 50%, with an error margin of
20%, and a kappa of 0.75 against a null hypothesis of a
kappa of 0.6 (i.e., that the agreement is substantial, not
moderate), which would have required 199 assessments
made by two observers to achieve 90% power. Furthermore,
as this was intended to be an exploratory survey, we did
not evaluate discordance by grade of differentiation in tu-
mours or specific morphological prognostic characteristics.
The rather constrained nature of our diagnostic categor-
ies (benign, malignant, inflammatory, and suspicious)
reflects the immediate diagnostic needs in a region where
chronic inflammatory diseases like tuberculosis, neglected
tropical diseases (lymphatic filariasis, soil-transmitted
helminthiases, schistosomiasis, [25]), rhinosporidiosis,
actinomyces, or virus-related pathologies can cause organ
or tissue enlargement or tumour-like clinical presenta-
tions. There is also a need to rule out malignancy in the
biopsies of relatively frequent pathological fractures in
local children suffering from sickle cell anaemia [6], and
malignancy in the endometrium in a district with high
prevalence of molar pregnancies [10]. Furthermore, PAP
tests and cytology are usually assessed in terms of the
diagnostic categories we used [12].
The constrained nature of diagnostic categories we used
and the exploratory nature of the study also affect its com-
parability with other comparative reviews of surgical path-
ology laboratories. Nevertheless, our result of 13%
discordant cytological diagnoses with high hypothetical
clinical implications is in the range of major discordances
found by Kuijpers et al. (9.1 to 19.4%) in their study of a
routine review of fluid/FNA samples by expert cytopathol-
ogists. In that study, concordance was at 60.10%, while in
our survey it was 56.52%. Furthermore, the proportions of
discordance with high hypothetical clinical implications,
assuming that our definition overlaps the concept of
major error in surgical pathology described by Frable [9],
in general adult (5.6%), paediatric/adolescent (2.9%), and
lymphoproliferative (6.9%) pathological diagnoses were
somewhat higher than those reported in the review by
Frable [9], in which the reported rates of major errors in
all anatomical sites ranged from 0.26 to 5.7%.
Despite of these limitations, and taking into account that
our aim was to evaluate basic categorical discordance, we
chose to carry out a much less expensive survey instead of
performing the exhaustive process of evaluating pathology
misclassifications. Again, it is important to note that our
observers live on two different continents, including one in
a poor-resource environment. Therefore, we think that our
findings are of great value and certainly could be used as a
reference point for future analyses. We believe that one of
the key factors behind the high overall diagnostic concord-
ance we found was the long period of training at the BMC,
during which local personnel had the chance to work (and
learn) closely with experienced professionals.
Conclusion
In conclusion, this blind review on the concordance
between pathological and cytological diagnoses from a
country with a very high HDI and another with low HDI
seemed to be a sensitive and effective method for identify-
ing areas of potential error in cytology and surgical path-
ology according to Renshaw et al. [20, 21]. This study
shows the ability of local pathologists to compare their
findings with those of other reviewers, resulting in an
acceptable reproducibility with some limitations in cy-
tology and PAP tests, and represents a reference point that
can contribute to future, more detailed processes of qual-
ity control or audits, be they at the BMC or at other surgi-
cal pathology services in limited-resource regions. We
think that pathology departments in such settings deserve
to be encouraged and rewarded by the international scien-
tific community. Moreover, national governments need to
allocate specific funds to improve these laboratories and
to establish a stronger commitment to their personnel so
they can pursue continuing education programmes, learn
ancillary techniques, and optimise their supply of consum-
ables and their equipment maintenance.
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